120 related articles for article (PubMed ID: 34924112)
21. JNK/c-Jun signaling pathway mediates the fluoride-induced down-regulation of MMP-20 in vitro.
Zhang Y; Li W; Chi HS; Chen J; Denbesten PK
Matrix Biol; 2007 Oct; 26(8):633-41. PubMed ID: 17611094
[TBL] [Abstract][Full Text] [Related]
22. Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A.
Lee JY; Park HR; Oh YK; Kim YJ; Youn J; Han JS; Kim JM
J Mol Med (Berl); 2007 Dec; 85(12):1393-404. PubMed ID: 17639289
[TBL] [Abstract][Full Text] [Related]
23. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
24. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
[TBL] [Abstract][Full Text] [Related]
25. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
26. Stretch-induced IL-8 depends on c-Jun NH2-terminal and nuclear factor-kappaB-inducing kinases.
Li LF; Ouyang B; Choukroun G; Matyal R; Mascarenhas M; Jafari B; Bonventre JV; Force T; Quinn DA
Am J Physiol Lung Cell Mol Physiol; 2003 Aug; 285(2):L464-75. PubMed ID: 12716652
[TBL] [Abstract][Full Text] [Related]
27. Calcium has a permissive role in interleukin-1beta-induced c-jun N-terminal kinase activation in insulin-secreting cells.
Størling J; Zaitsev SV; Kapelioukh IL; Karlsen AE; Billestrup N; Berggren PO; Mandrup-Poulsen T
Endocrinology; 2005 Jul; 146(7):3026-36. PubMed ID: 15831571
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase.
Zohn IE; Yu H; Li X; Cox AD; Earp HS
Mol Cell Biol; 1995 Nov; 15(11):6160-8. PubMed ID: 7565768
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
30. IL-3-Induced Immediate Expression of c-
Fujita H; Fujita T; Fujii H
Cells; 2022 Apr; 11(9):. PubMed ID: 35563758
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.
Saatian B; Zhao Y; He D; Georas SN; Watkins T; Spannhake EW; Natarajan V
Biochem J; 2006 Feb; 393(Pt 3):657-68. PubMed ID: 16197369
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors.
Ma W; Gee K; Lim W; Chambers K; Angel JB; Kozlowski M; Kumar A
J Immunol; 2004 Jan; 172(1):318-30. PubMed ID: 14688340
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of interleukin 1β-stimulated interleukin-6 production by cranberry components in human gingival epithelial cells: effects on nuclear factor κB and activator protein 1 activation pathways.
Tipton DA; Carter TB; Dabbous MKh
J Periodontal Res; 2014 Aug; 49(4):437-47. PubMed ID: 23952046
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways.
Read MA; Whitley MZ; Gupta S; Pierce JW; Best J; Davis RJ; Collins T
J Biol Chem; 1997 Jan; 272(5):2753-61. PubMed ID: 9006914
[TBL] [Abstract][Full Text] [Related]
35. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.
De Bosscher K; Beck IM; Dejager L; Bougarne N; Gaigneaux A; Chateauvieux S; Ratman D; Bracke M; Tavernier J; Vanden Berghe W; Libert C; Diederich M; Haegeman G
Cell Mol Life Sci; 2014 Jan; 71(1):143-63. PubMed ID: 23784308
[TBL] [Abstract][Full Text] [Related]
36. IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes.
Wu CY; Hsieh HL; Sun CC; Yang CM
Glia; 2009 Dec; 57(16):1775-89. PubMed ID: 19455716
[TBL] [Abstract][Full Text] [Related]
37. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
[TBL] [Abstract][Full Text] [Related]
38. PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB.
Bark H; Choi CH
Cancer Chemother Pharmacol; 2010 May; 65(6):1131-6. PubMed ID: 19763573
[TBL] [Abstract][Full Text] [Related]
39. c-Jun-mediated anticancer mechanisms of tylophorine.
Yang CW; Lee YZ; Hsu HY; Wu CM; Chang HY; Chao YS; Lee SJ
Carcinogenesis; 2013 Jun; 34(6):1304-14. PubMed ID: 23385061
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-33 induces interleukin-8 expression via JNK/c-Jun/AP-1 pathway in human umbilical vein endothelial cells.
Umebashi K; Tokito A; Yamamoto M; Jougasaki M
PLoS One; 2018; 13(1):e0191659. PubMed ID: 29373608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]